Status:
TERMINATED
Assessment of Vulnerability to Carotid Stenosis by MultiModal Imaging and Cellular and Molecular Biology Analysis
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Internal Carotid Artery
Atheromatous Stenosis
Eligibility:
All Genders
18+ years
Brief Summary
Cerebrovascular accidents (CVA) are the second leading cause of death in France, and the most frequent cause of acquired physical and mental disability. Up to 90% of strokes are ischemic, among which ...
Eligibility Criteria
Inclusion
- Patients with symptomatic or asymptomatic atheromatous stenosis of the internal carotid artery, of a degree ≥ 50%, for which an operative indication is retained
- Scheduled surgery
Exclusion
- Samples collected from patients :
- who did not have a preoperative CT angiogram of the supra-aortic trunks
- with contraindication to MRI
- with contraindication to PET scan
- with a history of cervical radiotherapy
- with uncontrolled diabetes
- with a previous homolateral carotid endarterectomy
- who has already undergone angioplasty-stenting of the homolateral carotid artery
- with a neoplasia considered active / not cured
- Surgical procedure performed in emergency
Key Trial Info
Start Date :
February 14 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 26 2023
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05190510
Start Date
February 14 2022
End Date
January 26 2023
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourgogne
Dijon, France, 21000